Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-coding repressor of NFAT (NRON) is a long non-coding RNA (lncRNA) that negatively regulates the activity of the transcription factor NFAT by sequestering it in the cytoplasm within a multiprotein complex, thereby limiting its nuclear translocation and transcriptional activity. NRON functions as a scaffold that assembles regulatory proteins, including IQGAP1, KPNB1, and LRRK2, to retain phosphorylated NFAT outside the nucleus in resting cells. Upon stimulation or NRON knockdown, increased NFAT nuclear translocation occurs, enhancing NFAT-dependent gene expression such as cytokine production. NRON has been implicated in modulation of HIV replication by regulating NFAT activity in CD4 T cells, and altered NRON expression is associated with diseases like hepatocellular carcinoma and atrial fibrosis. NRON is not considered a conventional drug target (e.g., receptor, enzyme) at this time, but it is a key regulatory molecule in immune signaling and disease.
Not directly targeted by drugs; NRON functions by modulating the localization and activity of NFAT through sequestration in the cytoplasm, affecting downstream pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-coding repressor of NFAT (NRON).